Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Related Posts
Ozempic-Like Drug Failed to Treat Parkinson’s Disease in Trial
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other…
Vertex Experimental Drug Cuts Off Pain at the Source, Company Says
Vertex Pharmaceuticals said its medicine could address moderate to severe acute pain, and might be able to avoid the risk…
Workplace Wellness Programs Have Little Benefit, Study Finds
Employee mental health services have become a billion-dollar industry. New hires, once they have found the restrooms and enrolled in…